jesslzh personal page - To The Moon

jesslzh

jesslzh

No personal profile

12Follow

1Followers

0Topic

0Badge

2022-12-13

Great!

Sorry, the original content has been removed

2022-11-08

Thanks!

Sorry, the original content has been removed

2022-10-28

Sad

Down 32%, Is Disney a Buy?

2022-09-15

Up up up

EV Stocks Took off in Morning Trading, With Faraday Future Soaring Over 11% and Canoo Rising Nearly 5%

2022-09-15

Are vaccines still necessary?

Pfizer vs. Moderna: Which Vaccine-Maker Has More Upside?

2022-06-16

Noted

NIO Stock Falls 5% on Trademark Lawsuit

2022-06-16

Noted

Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale

Go to Tiger App to see more news

Invest in Global Markets with Tiger Brokers!

Open App

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4099173660726180","uuid":"4099173660726180","gmtCreate":1636090521129,"gmtModify":1636144407905,"name":"jesslzh","pinyin":"jesslzh","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":12,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.29","exceedPercentage":"80.23%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9923430029,"gmtCreate":1670892000361,"gmtModify":1676538454217,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099173660726180","authorIdStr":"4099173660726180"},"themes":[],"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9923430029","repostId":"2290205419","repostType":4,"isVote":1,"tweetType":1,"viewCount":1235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9987245053,"gmtCreate":1667943935572,"gmtModify":1676537986365,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099173660726180","authorIdStr":"4099173660726180"},"themes":[],"htmlText":"Thanks!","listText":"Thanks!","text":"Thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9987245053","repostId":"1117682161","repostType":4,"isVote":1,"tweetType":1,"viewCount":1000,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9986527554,"gmtCreate":1666996683978,"gmtModify":1676537845179,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099173660726180","authorIdStr":"4099173660726180"},"themes":[],"htmlText":"Sad","listText":"Sad","text":"Sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9986527554","repostId":"2278500004","repostType":4,"repost":{"id":"2278500004","kind":"highlight","pubTimestamp":1666969180,"share":"https://ttm.financial/m/news/2278500004?lang=&edition=full_marsco","pubTime":"2022-10-28 22:59","market":"us","language":"en","title":"Down 32%, Is Disney a Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2278500004","media":"Motley Fool","summary":"With iconic media properties, Disney is a household name. But is it a name worth buying after a steep sell-off?","content":"<html><head></head><body><p><b>Walt Disney</b> is an iconic name with worldwide recognition value. It owns a powerful collection of entertainment properties. And yet the stock has fallen by over 45% since peaking in early 2021. The shares are down by 32% in 2022 alone. However, there&#39;s a lot to unpack here before you hit the buy button.</p><h2>This makes sense, that doesn&#39;t</h2><p>Stock markets are often considered rational, but that&#39;s really when you look at the long term. Over short periods of time, Wall Street can make some pretty strange choices.</p><p>For example, when the coronavirus pandemic first hit in 2020, Disney&#39;s stock fell sharply. That was pretty logical, given that its amusement parks were shut down and the movies it made couldn&#39;t be released to theaters shut down by government fiat. Not shockingly, earnings were ugly. It got so bad that Disney eliminated its dividend.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/23ccba8ca3eb29e65ff75123790d57eb\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p>And then something unusual happened. The stock took off like a rocket ship, more than doubling in value between its pandemic lows and its early 2021 highs. The big story was the company&#39;s streaming business, which latched onto the digital theme driving many stocks as people worked from home and social distanced from each other.</p><p>The company did achieve notable success as it sought to compete with streaming giants like <b>Netflix</b> and <b>Amazon</b>. However, Disney&#39;s financial results didn&#39;t recover back to pre-pandemic levels, so the price spike appeared more emotionally driven than fundamentally sound.</p><p>Not surprisingly, as the euphoria wore off, and things like financial results started to gain more sway, the stock started to sell off again. Now, the shares are back to about where they were when the pandemic first hit. Is that a second chance to buy this iconic name, or just a reflection of reality?</p><h2>Positive and negative signs</h2><p>As noted, Disney&#39;s earnings are not back to pre-pandemic levels. So while the entertainment giant&#39;s business is recovering, it has not fully recovered. There are some notable reasons for this, including the fact that people have shifted the way they consume media. Cable television and movie theaters are both facing pressures and are core parts of Disney&#39;s business.</p><p>Notably, streaming has proven to be a cost-intensive and competitive business. In fact, Disney&#39;s &#34;direct to consumer&#34; segment lost over $1 billion in the third quarter of 2022 alone. That&#39;s a brutal cash drain for any company.</p><p>Overall, despite materially improved results, Disney&#39;s Q3 adjusted earnings only came in at $1.09 per share. Sure, that&#39;s up from $0.80 per share in 2021, but it&#39;s well below the $1.35 it earned in Q3 2019. Perhaps the big price drop makes sense, given that backdrop and the uncertainty around media consumption trends.</p><p>One particularly telling factor, meanwhile, is the dividend -- or, in this case, the lack of a dividend. It&#39;s perfectly understandable that Disney eliminated the dividend in 2020. But it has no plans to pay one in 2022 and hasn&#39;t given any direction about what investors should expect in the future.</p><p>If Disney&#39;s board of directors doesn&#39;t think the business has recovered enough to reinstate the dividend, perhaps it hasn&#39;t recovered enough to merit owning, either. Certainly dividend investors shouldn&#39;t buy it, but this nuance should probably be seen as a warning to other types of investors as well. The recovery story here is perhaps more complex than it seems.</p><h2>Not bad, but still plenty of uncertainty</h2><p>Disney is not a bad company by any stretch of the imagination. And it is clearly recovering from the pandemic hit. Investor sentiment, however, has been hard to predict and often looked unsupported by fundamentals. That&#39;s especially troubling given the push into the money-draining streaming space.</p><p>If you can stomach uncertainty, perhaps Disney is worth owning at current levels, even though the stock&#39;s price-to-earnings ratio is well above pre-COVID norms. This fact suggests that a recovery may already be priced into the shares.</p><p>Conservative investors, meanwhile, will probably be better off waiting for either a more developed recovery (perhaps highlighted by a dividend) or a clearer view of the future in the streaming space.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Down 32%, Is Disney a Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDown 32%, Is Disney a Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-28 22:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/28/down-32-is-disney-a-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Walt Disney is an iconic name with worldwide recognition value. It owns a powerful collection of entertainment properties. And yet the stock has fallen by over 45% since peaking in early 2021. The ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/28/down-32-is-disney-a-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2022/10/28/down-32-is-disney-a-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2278500004","content_text":"Walt Disney is an iconic name with worldwide recognition value. It owns a powerful collection of entertainment properties. And yet the stock has fallen by over 45% since peaking in early 2021. The shares are down by 32% in 2022 alone. However, there's a lot to unpack here before you hit the buy button.This makes sense, that doesn'tStock markets are often considered rational, but that's really when you look at the long term. Over short periods of time, Wall Street can make some pretty strange choices.For example, when the coronavirus pandemic first hit in 2020, Disney's stock fell sharply. That was pretty logical, given that its amusement parks were shut down and the movies it made couldn't be released to theaters shut down by government fiat. Not shockingly, earnings were ugly. It got so bad that Disney eliminated its dividend.Image source: Getty Images.And then something unusual happened. The stock took off like a rocket ship, more than doubling in value between its pandemic lows and its early 2021 highs. The big story was the company's streaming business, which latched onto the digital theme driving many stocks as people worked from home and social distanced from each other.The company did achieve notable success as it sought to compete with streaming giants like Netflix and Amazon. However, Disney's financial results didn't recover back to pre-pandemic levels, so the price spike appeared more emotionally driven than fundamentally sound.Not surprisingly, as the euphoria wore off, and things like financial results started to gain more sway, the stock started to sell off again. Now, the shares are back to about where they were when the pandemic first hit. Is that a second chance to buy this iconic name, or just a reflection of reality?Positive and negative signsAs noted, Disney's earnings are not back to pre-pandemic levels. So while the entertainment giant's business is recovering, it has not fully recovered. There are some notable reasons for this, including the fact that people have shifted the way they consume media. Cable television and movie theaters are both facing pressures and are core parts of Disney's business.Notably, streaming has proven to be a cost-intensive and competitive business. In fact, Disney's \"direct to consumer\" segment lost over $1 billion in the third quarter of 2022 alone. That's a brutal cash drain for any company.Overall, despite materially improved results, Disney's Q3 adjusted earnings only came in at $1.09 per share. Sure, that's up from $0.80 per share in 2021, but it's well below the $1.35 it earned in Q3 2019. Perhaps the big price drop makes sense, given that backdrop and the uncertainty around media consumption trends.One particularly telling factor, meanwhile, is the dividend -- or, in this case, the lack of a dividend. It's perfectly understandable that Disney eliminated the dividend in 2020. But it has no plans to pay one in 2022 and hasn't given any direction about what investors should expect in the future.If Disney's board of directors doesn't think the business has recovered enough to reinstate the dividend, perhaps it hasn't recovered enough to merit owning, either. Certainly dividend investors shouldn't buy it, but this nuance should probably be seen as a warning to other types of investors as well. The recovery story here is perhaps more complex than it seems.Not bad, but still plenty of uncertaintyDisney is not a bad company by any stretch of the imagination. And it is clearly recovering from the pandemic hit. Investor sentiment, however, has been hard to predict and often looked unsupported by fundamentals. That's especially troubling given the push into the money-draining streaming space.If you can stomach uncertainty, perhaps Disney is worth owning at current levels, even though the stock's price-to-earnings ratio is well above pre-COVID norms. This fact suggests that a recovery may already be priced into the shares.Conservative investors, meanwhile, will probably be better off waiting for either a more developed recovery (perhaps highlighted by a dividend) or a clearer view of the future in the streaming space.","news_type":1},"isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9934591920,"gmtCreate":1663281011461,"gmtModify":1676537240548,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099173660726180","authorIdStr":"4099173660726180"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9934591920","repostId":"1148570498","repostType":4,"repost":{"id":"1148570498","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1663249790,"share":"https://ttm.financial/m/news/1148570498?lang=&edition=full_marsco","pubTime":"2022-09-15 21:49","market":"us","language":"en","title":"EV Stocks Took off in Morning Trading, With Faraday Future Soaring Over 11% and Canoo Rising Nearly 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148570498","media":"Tiger Newspress","summary":"EV stocks took off in morning trading, with $Faraday Future Intelligent Electric Inc.(FFIE)$ soaring over 11% and $Canoo Inc.(GOEV)$ rising nearly 5%.","content":"<html><head></head><body><p>EV stocks took off in morning trading, with <a href=\"https://laohu8.com/S/FFIE\">Faraday Future Intelligent Electric Inc.</a> soaring over 11% and <a href=\"https://laohu8.com/S/GOEV\">Canoo Inc.</a> rising nearly 5%.<img src=\"https://static.tigerbbs.com/d55630e814b1927d668c6f95a774f051\" tg-width=\"259\" tg-height=\"391\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV Stocks Took off in Morning Trading, With Faraday Future Soaring Over 11% and Canoo Rising Nearly 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV Stocks Took off in Morning Trading, With Faraday Future Soaring Over 11% and Canoo Rising Nearly 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-09-15 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>EV stocks took off in morning trading, with <a href=\"https://laohu8.com/S/FFIE\">Faraday Future Intelligent Electric Inc.</a> soaring over 11% and <a href=\"https://laohu8.com/S/GOEV\">Canoo Inc.</a> rising nearly 5%.<img src=\"https://static.tigerbbs.com/d55630e814b1927d668c6f95a774f051\" tg-width=\"259\" tg-height=\"391\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148570498","content_text":"EV stocks took off in morning trading, with Faraday Future Intelligent Electric Inc. soaring over 11% and Canoo Inc. rising nearly 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1071,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9934593075,"gmtCreate":1663280963398,"gmtModify":1676537240515,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099173660726180","authorIdStr":"4099173660726180"},"themes":[],"htmlText":"Are vaccines still necessary?&nbsp;","listText":"Are vaccines still necessary?&nbsp;","text":"Are vaccines still necessary?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9934593075","repostId":"1112685413","repostType":4,"repost":{"id":"1112685413","kind":"news","pubTimestamp":1663252053,"share":"https://ttm.financial/m/news/1112685413?lang=&edition=full_marsco","pubTime":"2022-09-15 22:27","market":"us","language":"en","title":"Pfizer vs. Moderna: Which Vaccine-Maker Has More Upside?","url":"https://stock-news.laohu8.com/highlight/detail?id=1112685413","media":"TipRanks","summary":"Story HighlightsPfizer and Moderna are top COVID-19 stocks that could continue to be winners well af","content":"<div>\n<p>Story HighlightsPfizer and Moderna are top COVID-19 stocks that could continue to be winners well after the pandemic is over. Let’s check in with each stock and see where Wall Street stands on each ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/pfizer-vs-moderna-which-vaccine-maker-has-more-upside\">Web Link</a>\n\n</div>\n","source":"lsy1606183248679","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer vs. Moderna: Which Vaccine-Maker Has More Upside?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer vs. Moderna: Which Vaccine-Maker Has More Upside?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-15 22:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/article/pfizer-vs-moderna-which-vaccine-maker-has-more-upside><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Story HighlightsPfizer and Moderna are top COVID-19 stocks that could continue to be winners well after the pandemic is over. Let’s check in with each stock and see where Wall Street stands on each ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/pfizer-vs-moderna-which-vaccine-maker-has-more-upside\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.tipranks.com/news/article/pfizer-vs-moderna-which-vaccine-maker-has-more-upside","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112685413","content_text":"Story HighlightsPfizer and Moderna are top COVID-19 stocks that could continue to be winners well after the pandemic is over. Let’s check in with each stock and see where Wall Street stands on each name.Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) are the big-two COVID-19 vaccine makers that have seen shares fall back to Earth in recent months. Although both stocks may look tempting to investors, I believe Pfizer may have more upside potential.Undoubtedly, we’re still in a pandemic, but things are pretty much back to normal. America has reopened its doors, and things are unlikely to change, even if a new Omicron variant sparks an outbreak for the fall or winter season.Indeed, booster shots are a major reason the American economy can keep its doors open as the coronavirus continues spreading. We’ve learned to live with the disease, and with no end to the pandemic in sight, Pfizer and Moderna stand to continue extending their vaccine windfalls.In due time, the pandemic will end, and demand for vaccines could begin to fall alongside the severity of future strains. Nobody expected Pfizer or Moderna’s COVID-19 businesses to continue raking in impressive cash flows forever. Each stock sports a low single-digit price-to-earnings (P/E) multiple in anticipation of a drastic fall-off in vaccine demand.In any case, Pfizer and Moderna are two biopharma companies with innovation in their veins. The potential of mRNA technology could have the potential to be far-reaching, and it’s these two plays that seem like terrific buys on the dip, even as they move beyond COVID-19.With Moderna going after Pfizer and BioNTech for COVID-19 vaccine patent infringement, the two COVID-19 rivals could find themselves in a legal tussle for quite some time. In any case, don’t expect such a suit to impact supply ahead of future COVID-19 waves.Let’s look closely at Pfizer and Moderna to see how each firm stacks up going into a recession year and a post-COVID environment.PfizerPfizer is a biopharma behemoth that’s been on quite a spending spree of late, with the acquisition of Biohaven Pharmaceuticals for $11.6 billion and Blood Therapeutics for $5.4 billion. Such deals are intriguing and seem to be a terrific use of excess funds from the COVID-19 business.As Pfizer continues making considerable sums on booster shots, investors can expect Pfizer to continue to pursue opportunities in the space to keep its pipeline full and its growth rate elevated.Undoubtedly, Pfizer doesn’t have a track record for growth. It’s a $260 billion behemoth that’s been weighed down by a generics business for many years. With the generics business spun off and a new focus on growth, Pfizer seems more than capable of growing like a firm that’s a fraction of its size.The Biohaven and Blood Therapeutics deals add an impressive portfolio of drugs aboard, as well as promising candidates that could have blockbuster potential in the future. With Biohaven, Pfizer gains a promising migraine business and third-generation glutamate-modulation platform Troriluzole, among other very intriguing offerings. The migraine franchise should do wonders for helping Pfizer hold its own in the latter half of the decade once the COVID-19 business winds down.It isn’t just the migraine business that’s intriguing. Troriluzole is in phase three of clinical trials for treating OCD (obsessive-compulsive disorder) and Spinocerebellar Ataxia (SCA). The drug has blockbuster potential and could help Pfizer transition into a post-Comirnaty world.Pfizer is readying for the end of the COVID-19 windfall, but the COVID business may still have room to run into 2023 or even 2024. It’s hard to tell when the pandemic will end, but even if it doesn’t, Pfizer’s boosters and oral treatments will be vital in keeping things normal for the duration of the pandemic.Pfizer stock looks like a cheap biopharma stock to make it through a recession year. At writing, the stock trades at 8.9 times trailing earnings and just 2.7 times sales.Is Pfizer Stock a Buy, Sell, or Hold?Wall Street is bullish but muted on Pfizer stock with a Moderate Buy consensus rating. This is based on four Buys and seven Holds assigned in the past three months. With an average PFE stock price target of $56.20, analysts expect a 22% upside potential.ModernaModerna is betting big on mRNA technology, with a pipeline full of innovations with blockbuster potential. Unlike Pfizer, Moderna has more to lose if COVID-19 vaccine demand dissipates. In any case, demand may not be so quick to fade as the world gears for another wave of spread. In the latest quarter, Moderna saw COVID-19 vaccine revenues rise 8%. The company is on its way to hitting its $21 billion sales estimate.Beyond COVID-19, Moderna stock is more of a question mark. Various vaccine trials — including RSV (respiratory virus) — are in the late stages and could help spark the next leg higher for the stock, even if the economy falls into a recession over the next few months.Indeed, Moderna stock has the potential to fuel a lowly-correlated return moving forward. In any case, it’s all about boosters as the firm pushes for its next big thing. For a firm that delivered one of the biggest innovations with Spikevax over the past few years, I think Moderna can pull off another breakthrough.For now, investors are curbing their expectations. The stock boasts a 4.6 times trailing earnings multiple and a 2.7 times sales multiple. That’s not at all indicative of a pioneer in a nascent market full of potential. I don’t think Moderna stock is a trap or a one-hit wonder, even if vaccine demand were to sink rapidly through 2023. The pipeline is full of too much promise.What is the Price Target for MRNA Stock?Wall Street expects Moderna’s returns to be promising over the next year. Similar to Pfizer, analysts have a Moderate Buy consensus rating on Moderna based on four Buys, five Holds, and one Sell. However, with an average MRNA stock price target of $209.60, the upside potential equates to 50.8%.Takeaway: Pfizer Might be the Better BuyModerna and Pfizer are both great bets following their recent declines (23% and 71%, respectively). However, at this juncture, I prefer Pfizer stock because it looks better prepared for a move into a post-pandemic environment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":901,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9054436280,"gmtCreate":1655422454340,"gmtModify":1676535634069,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099173660726180","authorIdStr":"4099173660726180"},"themes":[],"htmlText":"Noted&nbsp;","listText":"Noted&nbsp;","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9054436280","repostId":"1186706257","repostType":4,"repost":{"id":"1186706257","kind":"news","pubTimestamp":1655390954,"share":"https://ttm.financial/m/news/1186706257?lang=&edition=full_marsco","pubTime":"2022-06-16 22:49","market":"us","language":"en","title":"NIO Stock Falls 5% on Trademark Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=1186706257","media":"InvestorPlace","summary":"Nio(NIO) is down 4% today on news that European rival Volkswagen's(VWAGY) Audi has filed a trademark","content":"<html><head></head><body><ul><li><b>Nio</b>(<b><u>NIO</u></b>) is down 4% today on news that European rival <b>Volkswagen&#39;s</b>(<b><u>VWAGY</u></b>) Audi has filed a trademark infringement lawsuit against it.</li><li>At the same time, Jeffries has cut its forecast for electric vehicle (EV) sales this year and next, putting pressure on all EV stocks.</li><li>The lawsuit from Audi threatens to hurt Nio&#39;s European expansion plans.</li></ul><p>Shares of <b>Nio</b>(NYSE:<b><u>NIO</u></b>) are down 4% today on news that the Chinese electric vehicle (EV) maker is facing legal action from rival <b>Volkswagen’s</b>(OTCMKTS:<b><u>VWAGY</u></b>) Audi over an alleged trademark violation. Reports of the lawsuit come at the same time Jeffries slashed its price target for EV sales, setting NIO stock up for a very bad trading day.</p><p>Ironically, today’s downturn comes a day after Nio’sshare price rose more than 13% after a product launch in which it revealed its long-awaited ES7 electric SUV. So far in 2022, NIO stock has fallen more than 40% to trade at less than $20 per share.</p><p><b>What Happened With NIO Stock</b></p><p>The most consequential news is that Audi has filed a lawsuit in a Munich court against Nio, alleging the Shanghai-based company has infringed on its trademark. Specifically, the company claims Nio’s decision to name two of its models ES6 infringes on Audi’s trademark for its own S6 and S8 model vehicles.</p><p>Nio, whose sales are predominantly in China, is now pushing into the European automotive market. It entered Norway last year with plans to begin sales in Germany, the Netherlands, Sweden and Denmark this year. Nio has said it expects to initiate its sales in Germany with its ET7 electric sedan.</p><p>At the same time, Jeffries Financial Group lowered it forecast for worldwide EV sales this year to 8.7 million from 9 million previously. It also lowered its 2023 estimate to 11.5 million, down from an earlier estimate of 11.8 million. Jeffries cited the impact of inflation and higher interest rates as the reasons for its diminished outlook.</p><p><b>Why It Matters</b></p><p>The Audi lawsuit is the latest blow to Nio’s share price this year. In recent months, the company has also had to contend with an investigation by the U.S. Securities and Exchange Commission (SEC) into its accounting practices. Nio has also faced slower-than-expected production due to Covid-19 lockdowns in China and was forced to list its shares on the <b>Singapore Exchange</b> over concerns that it might be delisted in New York.</p><p>For the electric vehicle sector, Jeffries sales downgrade also comes at a bad time. In recent days,<b>Ford</b>(NYSE:<b><u>F</u></b>) announced that it is recalling 50,000 of its Mustang Mach-EEV over safety issues. Additionally, <b>Tesla</b>(NASDAQ:<b><u>TSLA</u></b>) has come under public fire over its safety record and the autopilot system found in its vehicles. At the same time, Chinese automakers have been hobbled by production shutdowns due to Covid-19 lockdowns.</p><p><b>What’s Next for NIO Stock</b></p><p>It will be important to see if Nio can resolve the trademark dispute with Audi quickly and with little financial penalty for the automaker. A protracted legal battle will not help NIO stock or the company’s European expansion. In the meantime, Nio’s share price continues to come under pressure and fall lower.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO Stock Falls 5% on Trademark Lawsuit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO Stock Falls 5% on Trademark Lawsuit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-16 22:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/06/nio-stock-falls-5-on-trademark-lawsuit/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nio(NIO) is down 4% today on news that European rival Volkswagen's(VWAGY) Audi has filed a trademark infringement lawsuit against it.At the same time, Jeffries has cut its forecast for electric ...</p>\n\n<a href=\"https://investorplace.com/2022/06/nio-stock-falls-5-on-trademark-lawsuit/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://investorplace.com/2022/06/nio-stock-falls-5-on-trademark-lawsuit/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186706257","content_text":"Nio(NIO) is down 4% today on news that European rival Volkswagen's(VWAGY) Audi has filed a trademark infringement lawsuit against it.At the same time, Jeffries has cut its forecast for electric vehicle (EV) sales this year and next, putting pressure on all EV stocks.The lawsuit from Audi threatens to hurt Nio's European expansion plans.Shares of Nio(NYSE:NIO) are down 4% today on news that the Chinese electric vehicle (EV) maker is facing legal action from rival Volkswagen’s(OTCMKTS:VWAGY) Audi over an alleged trademark violation. Reports of the lawsuit come at the same time Jeffries slashed its price target for EV sales, setting NIO stock up for a very bad trading day.Ironically, today’s downturn comes a day after Nio’sshare price rose more than 13% after a product launch in which it revealed its long-awaited ES7 electric SUV. So far in 2022, NIO stock has fallen more than 40% to trade at less than $20 per share.What Happened With NIO StockThe most consequential news is that Audi has filed a lawsuit in a Munich court against Nio, alleging the Shanghai-based company has infringed on its trademark. Specifically, the company claims Nio’s decision to name two of its models ES6 infringes on Audi’s trademark for its own S6 and S8 model vehicles.Nio, whose sales are predominantly in China, is now pushing into the European automotive market. It entered Norway last year with plans to begin sales in Germany, the Netherlands, Sweden and Denmark this year. Nio has said it expects to initiate its sales in Germany with its ET7 electric sedan.At the same time, Jeffries Financial Group lowered it forecast for worldwide EV sales this year to 8.7 million from 9 million previously. It also lowered its 2023 estimate to 11.5 million, down from an earlier estimate of 11.8 million. Jeffries cited the impact of inflation and higher interest rates as the reasons for its diminished outlook.Why It MattersThe Audi lawsuit is the latest blow to Nio’s share price this year. In recent months, the company has also had to contend with an investigation by the U.S. Securities and Exchange Commission (SEC) into its accounting practices. Nio has also faced slower-than-expected production due to Covid-19 lockdowns in China and was forced to list its shares on the Singapore Exchange over concerns that it might be delisted in New York.For the electric vehicle sector, Jeffries sales downgrade also comes at a bad time. In recent days,Ford(NYSE:F) announced that it is recalling 50,000 of its Mustang Mach-EEV over safety issues. Additionally, Tesla(NASDAQ:TSLA) has come under public fire over its safety record and the autopilot system found in its vehicles. At the same time, Chinese automakers have been hobbled by production shutdowns due to Covid-19 lockdowns.What’s Next for NIO StockIt will be important to see if Nio can resolve the trademark dispute with Audi quickly and with little financial penalty for the automaker. A protracted legal battle will not help NIO stock or the company’s European expansion. In the meantime, Nio’s share price continues to come under pressure and fall lower.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9054438834,"gmtCreate":1655422403928,"gmtModify":1676535634044,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099173660726180","authorIdStr":"4099173660726180"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9054438834","repostId":"2243842651","repostType":4,"repost":{"id":"2243842651","kind":"highlight","pubTimestamp":1655391848,"share":"https://ttm.financial/m/news/2243842651?lang=&edition=full_marsco","pubTime":"2022-06-16 23:04","market":"us","language":"en","title":"Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2243842651","media":"Motley Fool","summary":"These two blue-chip financial companies have been undervalued for a while.","content":"<html><head></head><body><p>The <b>S&amp;P 500</b> dipped into bear market territory earlier this week, down more than 20% from its early January peak. The broader market drop has brought down the valuations of some individual good stocks in numerous sectors and industries.</p><p>I&#39;ve had my eye on two stocks that have been on sale for quite a while now and were trading lower even before the market began to tank in November. For whatever reasons, investors have undervalued them despite their strong performances. Should investors take a chance on these two sale-priced stocks? Let&#39;s take a closer look.</p><h2>1. The case for Goldman Sachs</h2><p><b>Goldman Sachs</b> is currently trading at about $290 per share, down about 24% year to date, and based on its fundamentals and outlook, that&#39;s a bargain valuation.</p><p>The investment banking giant has a price-to-earnings (P/E) ratio of 5.6 and a forward P/E ratio of 7.7.</p><p>Further, consider its 5-year price/earnings-to-growth (PEG) ratio -- a metric that weighs the stock price relative to its expected earnings growth. At 0.2, that&#39;s another indicator of a cheap stock, as any PEG ratio under 1 is considered undervalued.</p><p>It&#39;s also trading at a price-to-book (P/B) ratio of 0.9 -- another sign that it&#39;s discounted, as a P/B of 1 indicates a stock trading at its actual value.</p><p>So why is Goldman Sachs a good buy at this low valuation? It is a market leader in two of its businesses, investment banking and global markets -- which is its institutional trading arm. While mergers and acquisitions activity has slowed considerably compared to last year, Goldman Sachs is still the leader in deals so far in 2022. And while equity trading has slowed, too, Goldman Sachs had a record quarter for fixed income trading. Also, it experienced strong growth in its consumer banking/wealth management businesses, which saw revenue increase 21% year over year. This offset losses in the asset management business, which suffered due to an overall decline in assets due to the falling stock market.</p><p>Even after its declines in this bear market, Goldman Sachs&#39; market leadership and diversity of revenue sources have it trading at a price nearly twice as much as it was at the bottom of its early pandemic plunge in March 2020. Yet it&#39;s still cheap by these metrics, which makes this a good time to pick up shares of this blue-chip financial institution.</p><h2>2. The case for Citigroup</h2><p>You certainly don&#39;t have to wait for a market crash to get <b>Citigroup</b> at a low valuation. The nation&#39;s third-largest bank by assets has been undervalued for several years now, due in part to the pandemic, but also due to its own issues related to risk management.</p><p>But Citigroup has been a relative outperformer compared to its megabank peers in 2022. It&#39;s only down about 20% year to date, and it remains extremely undervalued. It has a P/E ratio of 5.6 and a forward P/E of 7, with a PEG ratio of 0.4. Also, it has a P/B ratio of just 0.5. All of those metrics indicate a stock trading well below its value.</p><p>Renowned value stock investor Warren Buffett, chairman and CEO of <b>Berkshire Hathaway</b>, recognized that, as he added Citigroup to the conglomerate&#39;s portfolio in the first quarter.</p><p>What Buffett likely saw was that Citi was trading at a deep discount due in large part to its own past mistakes, but that the bank has made some key changes. Those started with bringing in a new CEO, Jane Fraser, who has refocused its strategy on its strengths and exited businesses that have underperformed. It has also invested close to $1 billion to improve its internal controls.</p><p>While Citigroup&#39;s transformation won&#39;t happen overnight, it&#39;s a good buy at this valuation. And the current rising interest rate environment should benefit it by boosting its interest income, as long as inflation can be brought into check and the U.S. economy doesn&#39;t fall into a recession.</p><p>When the economy and markets do eventually turn around, these two undervalued stocks will be in a good position to grow.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon't Wait for a Market Crash: These 2 Top Stocks Are on Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-16 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/06/16/dont-wait-for-market-crash-top-stocks-on-sale/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The S&P 500 dipped into bear market territory earlier this week, down more than 20% from its early January peak. The broader market drop has brought down the valuations of some individual good stocks ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/06/16/dont-wait-for-market-crash-top-stocks-on-sale/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛","C":"花旗"},"source_url":"https://www.fool.com/investing/2022/06/16/dont-wait-for-market-crash-top-stocks-on-sale/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2243842651","content_text":"The S&P 500 dipped into bear market territory earlier this week, down more than 20% from its early January peak. The broader market drop has brought down the valuations of some individual good stocks in numerous sectors and industries.I've had my eye on two stocks that have been on sale for quite a while now and were trading lower even before the market began to tank in November. For whatever reasons, investors have undervalued them despite their strong performances. Should investors take a chance on these two sale-priced stocks? Let's take a closer look.1. The case for Goldman SachsGoldman Sachs is currently trading at about $290 per share, down about 24% year to date, and based on its fundamentals and outlook, that's a bargain valuation.The investment banking giant has a price-to-earnings (P/E) ratio of 5.6 and a forward P/E ratio of 7.7.Further, consider its 5-year price/earnings-to-growth (PEG) ratio -- a metric that weighs the stock price relative to its expected earnings growth. At 0.2, that's another indicator of a cheap stock, as any PEG ratio under 1 is considered undervalued.It's also trading at a price-to-book (P/B) ratio of 0.9 -- another sign that it's discounted, as a P/B of 1 indicates a stock trading at its actual value.So why is Goldman Sachs a good buy at this low valuation? It is a market leader in two of its businesses, investment banking and global markets -- which is its institutional trading arm. While mergers and acquisitions activity has slowed considerably compared to last year, Goldman Sachs is still the leader in deals so far in 2022. And while equity trading has slowed, too, Goldman Sachs had a record quarter for fixed income trading. Also, it experienced strong growth in its consumer banking/wealth management businesses, which saw revenue increase 21% year over year. This offset losses in the asset management business, which suffered due to an overall decline in assets due to the falling stock market.Even after its declines in this bear market, Goldman Sachs' market leadership and diversity of revenue sources have it trading at a price nearly twice as much as it was at the bottom of its early pandemic plunge in March 2020. Yet it's still cheap by these metrics, which makes this a good time to pick up shares of this blue-chip financial institution.2. The case for CitigroupYou certainly don't have to wait for a market crash to get Citigroup at a low valuation. The nation's third-largest bank by assets has been undervalued for several years now, due in part to the pandemic, but also due to its own issues related to risk management.But Citigroup has been a relative outperformer compared to its megabank peers in 2022. It's only down about 20% year to date, and it remains extremely undervalued. It has a P/E ratio of 5.6 and a forward P/E of 7, with a PEG ratio of 0.4. Also, it has a P/B ratio of just 0.5. All of those metrics indicate a stock trading well below its value.Renowned value stock investor Warren Buffett, chairman and CEO of Berkshire Hathaway, recognized that, as he added Citigroup to the conglomerate's portfolio in the first quarter.What Buffett likely saw was that Citi was trading at a deep discount due in large part to its own past mistakes, but that the bank has made some key changes. Those started with bringing in a new CEO, Jane Fraser, who has refocused its strategy on its strengths and exited businesses that have underperformed. It has also invested close to $1 billion to improve its internal controls.While Citigroup's transformation won't happen overnight, it's a good buy at this valuation. And the current rising interest rate environment should benefit it by boosting its interest income, as long as inflation can be brought into check and the U.S. economy doesn't fall into a recession.When the economy and markets do eventually turn around, these two undervalued stocks will be in a good position to grow.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9987245053,"gmtCreate":1667943935572,"gmtModify":1676537986365,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099173660726180","idStr":"4099173660726180"},"themes":[],"htmlText":"Thanks!","listText":"Thanks!","text":"Thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9987245053","repostId":"1117682161","repostType":4,"isVote":1,"tweetType":1,"viewCount":1000,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9986527554,"gmtCreate":1666996683978,"gmtModify":1676537845179,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099173660726180","idStr":"4099173660726180"},"themes":[],"htmlText":"Sad","listText":"Sad","text":"Sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9986527554","repostId":"2278500004","repostType":4,"repost":{"id":"2278500004","kind":"highlight","pubTimestamp":1666969180,"share":"https://ttm.financial/m/news/2278500004?lang=&edition=full_marsco","pubTime":"2022-10-28 22:59","market":"us","language":"en","title":"Down 32%, Is Disney a Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2278500004","media":"Motley Fool","summary":"With iconic media properties, Disney is a household name. But is it a name worth buying after a steep sell-off?","content":"<html><head></head><body><p><b>Walt Disney</b> is an iconic name with worldwide recognition value. It owns a powerful collection of entertainment properties. And yet the stock has fallen by over 45% since peaking in early 2021. The shares are down by 32% in 2022 alone. However, there&#39;s a lot to unpack here before you hit the buy button.</p><h2>This makes sense, that doesn&#39;t</h2><p>Stock markets are often considered rational, but that&#39;s really when you look at the long term. Over short periods of time, Wall Street can make some pretty strange choices.</p><p>For example, when the coronavirus pandemic first hit in 2020, Disney&#39;s stock fell sharply. That was pretty logical, given that its amusement parks were shut down and the movies it made couldn&#39;t be released to theaters shut down by government fiat. Not shockingly, earnings were ugly. It got so bad that Disney eliminated its dividend.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/23ccba8ca3eb29e65ff75123790d57eb\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p>And then something unusual happened. The stock took off like a rocket ship, more than doubling in value between its pandemic lows and its early 2021 highs. The big story was the company&#39;s streaming business, which latched onto the digital theme driving many stocks as people worked from home and social distanced from each other.</p><p>The company did achieve notable success as it sought to compete with streaming giants like <b>Netflix</b> and <b>Amazon</b>. However, Disney&#39;s financial results didn&#39;t recover back to pre-pandemic levels, so the price spike appeared more emotionally driven than fundamentally sound.</p><p>Not surprisingly, as the euphoria wore off, and things like financial results started to gain more sway, the stock started to sell off again. Now, the shares are back to about where they were when the pandemic first hit. Is that a second chance to buy this iconic name, or just a reflection of reality?</p><h2>Positive and negative signs</h2><p>As noted, Disney&#39;s earnings are not back to pre-pandemic levels. So while the entertainment giant&#39;s business is recovering, it has not fully recovered. There are some notable reasons for this, including the fact that people have shifted the way they consume media. Cable television and movie theaters are both facing pressures and are core parts of Disney&#39;s business.</p><p>Notably, streaming has proven to be a cost-intensive and competitive business. In fact, Disney&#39;s &#34;direct to consumer&#34; segment lost over $1 billion in the third quarter of 2022 alone. That&#39;s a brutal cash drain for any company.</p><p>Overall, despite materially improved results, Disney&#39;s Q3 adjusted earnings only came in at $1.09 per share. Sure, that&#39;s up from $0.80 per share in 2021, but it&#39;s well below the $1.35 it earned in Q3 2019. Perhaps the big price drop makes sense, given that backdrop and the uncertainty around media consumption trends.</p><p>One particularly telling factor, meanwhile, is the dividend -- or, in this case, the lack of a dividend. It&#39;s perfectly understandable that Disney eliminated the dividend in 2020. But it has no plans to pay one in 2022 and hasn&#39;t given any direction about what investors should expect in the future.</p><p>If Disney&#39;s board of directors doesn&#39;t think the business has recovered enough to reinstate the dividend, perhaps it hasn&#39;t recovered enough to merit owning, either. Certainly dividend investors shouldn&#39;t buy it, but this nuance should probably be seen as a warning to other types of investors as well. The recovery story here is perhaps more complex than it seems.</p><h2>Not bad, but still plenty of uncertainty</h2><p>Disney is not a bad company by any stretch of the imagination. And it is clearly recovering from the pandemic hit. Investor sentiment, however, has been hard to predict and often looked unsupported by fundamentals. That&#39;s especially troubling given the push into the money-draining streaming space.</p><p>If you can stomach uncertainty, perhaps Disney is worth owning at current levels, even though the stock&#39;s price-to-earnings ratio is well above pre-COVID norms. This fact suggests that a recovery may already be priced into the shares.</p><p>Conservative investors, meanwhile, will probably be better off waiting for either a more developed recovery (perhaps highlighted by a dividend) or a clearer view of the future in the streaming space.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Down 32%, Is Disney a Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDown 32%, Is Disney a Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-28 22:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/28/down-32-is-disney-a-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Walt Disney is an iconic name with worldwide recognition value. It owns a powerful collection of entertainment properties. And yet the stock has fallen by over 45% since peaking in early 2021. The ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/28/down-32-is-disney-a-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2022/10/28/down-32-is-disney-a-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2278500004","content_text":"Walt Disney is an iconic name with worldwide recognition value. It owns a powerful collection of entertainment properties. And yet the stock has fallen by over 45% since peaking in early 2021. The shares are down by 32% in 2022 alone. However, there's a lot to unpack here before you hit the buy button.This makes sense, that doesn'tStock markets are often considered rational, but that's really when you look at the long term. Over short periods of time, Wall Street can make some pretty strange choices.For example, when the coronavirus pandemic first hit in 2020, Disney's stock fell sharply. That was pretty logical, given that its amusement parks were shut down and the movies it made couldn't be released to theaters shut down by government fiat. Not shockingly, earnings were ugly. It got so bad that Disney eliminated its dividend.Image source: Getty Images.And then something unusual happened. The stock took off like a rocket ship, more than doubling in value between its pandemic lows and its early 2021 highs. The big story was the company's streaming business, which latched onto the digital theme driving many stocks as people worked from home and social distanced from each other.The company did achieve notable success as it sought to compete with streaming giants like Netflix and Amazon. However, Disney's financial results didn't recover back to pre-pandemic levels, so the price spike appeared more emotionally driven than fundamentally sound.Not surprisingly, as the euphoria wore off, and things like financial results started to gain more sway, the stock started to sell off again. Now, the shares are back to about where they were when the pandemic first hit. Is that a second chance to buy this iconic name, or just a reflection of reality?Positive and negative signsAs noted, Disney's earnings are not back to pre-pandemic levels. So while the entertainment giant's business is recovering, it has not fully recovered. There are some notable reasons for this, including the fact that people have shifted the way they consume media. Cable television and movie theaters are both facing pressures and are core parts of Disney's business.Notably, streaming has proven to be a cost-intensive and competitive business. In fact, Disney's \"direct to consumer\" segment lost over $1 billion in the third quarter of 2022 alone. That's a brutal cash drain for any company.Overall, despite materially improved results, Disney's Q3 adjusted earnings only came in at $1.09 per share. Sure, that's up from $0.80 per share in 2021, but it's well below the $1.35 it earned in Q3 2019. Perhaps the big price drop makes sense, given that backdrop and the uncertainty around media consumption trends.One particularly telling factor, meanwhile, is the dividend -- or, in this case, the lack of a dividend. It's perfectly understandable that Disney eliminated the dividend in 2020. But it has no plans to pay one in 2022 and hasn't given any direction about what investors should expect in the future.If Disney's board of directors doesn't think the business has recovered enough to reinstate the dividend, perhaps it hasn't recovered enough to merit owning, either. Certainly dividend investors shouldn't buy it, but this nuance should probably be seen as a warning to other types of investors as well. The recovery story here is perhaps more complex than it seems.Not bad, but still plenty of uncertaintyDisney is not a bad company by any stretch of the imagination. And it is clearly recovering from the pandemic hit. Investor sentiment, however, has been hard to predict and often looked unsupported by fundamentals. That's especially troubling given the push into the money-draining streaming space.If you can stomach uncertainty, perhaps Disney is worth owning at current levels, even though the stock's price-to-earnings ratio is well above pre-COVID norms. This fact suggests that a recovery may already be priced into the shares.Conservative investors, meanwhile, will probably be better off waiting for either a more developed recovery (perhaps highlighted by a dividend) or a clearer view of the future in the streaming space.","news_type":1},"isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9054436280,"gmtCreate":1655422454340,"gmtModify":1676535634069,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099173660726180","idStr":"4099173660726180"},"themes":[],"htmlText":"Noted&nbsp;","listText":"Noted&nbsp;","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9054436280","repostId":"1186706257","repostType":4,"repost":{"id":"1186706257","kind":"news","pubTimestamp":1655390954,"share":"https://ttm.financial/m/news/1186706257?lang=&edition=full_marsco","pubTime":"2022-06-16 22:49","market":"us","language":"en","title":"NIO Stock Falls 5% on Trademark Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=1186706257","media":"InvestorPlace","summary":"Nio(NIO) is down 4% today on news that European rival Volkswagen's(VWAGY) Audi has filed a trademark","content":"<html><head></head><body><ul><li><b>Nio</b>(<b><u>NIO</u></b>) is down 4% today on news that European rival <b>Volkswagen&#39;s</b>(<b><u>VWAGY</u></b>) Audi has filed a trademark infringement lawsuit against it.</li><li>At the same time, Jeffries has cut its forecast for electric vehicle (EV) sales this year and next, putting pressure on all EV stocks.</li><li>The lawsuit from Audi threatens to hurt Nio&#39;s European expansion plans.</li></ul><p>Shares of <b>Nio</b>(NYSE:<b><u>NIO</u></b>) are down 4% today on news that the Chinese electric vehicle (EV) maker is facing legal action from rival <b>Volkswagen’s</b>(OTCMKTS:<b><u>VWAGY</u></b>) Audi over an alleged trademark violation. Reports of the lawsuit come at the same time Jeffries slashed its price target for EV sales, setting NIO stock up for a very bad trading day.</p><p>Ironically, today’s downturn comes a day after Nio’sshare price rose more than 13% after a product launch in which it revealed its long-awaited ES7 electric SUV. So far in 2022, NIO stock has fallen more than 40% to trade at less than $20 per share.</p><p><b>What Happened With NIO Stock</b></p><p>The most consequential news is that Audi has filed a lawsuit in a Munich court against Nio, alleging the Shanghai-based company has infringed on its trademark. Specifically, the company claims Nio’s decision to name two of its models ES6 infringes on Audi’s trademark for its own S6 and S8 model vehicles.</p><p>Nio, whose sales are predominantly in China, is now pushing into the European automotive market. It entered Norway last year with plans to begin sales in Germany, the Netherlands, Sweden and Denmark this year. Nio has said it expects to initiate its sales in Germany with its ET7 electric sedan.</p><p>At the same time, Jeffries Financial Group lowered it forecast for worldwide EV sales this year to 8.7 million from 9 million previously. It also lowered its 2023 estimate to 11.5 million, down from an earlier estimate of 11.8 million. Jeffries cited the impact of inflation and higher interest rates as the reasons for its diminished outlook.</p><p><b>Why It Matters</b></p><p>The Audi lawsuit is the latest blow to Nio’s share price this year. In recent months, the company has also had to contend with an investigation by the U.S. Securities and Exchange Commission (SEC) into its accounting practices. Nio has also faced slower-than-expected production due to Covid-19 lockdowns in China and was forced to list its shares on the <b>Singapore Exchange</b> over concerns that it might be delisted in New York.</p><p>For the electric vehicle sector, Jeffries sales downgrade also comes at a bad time. In recent days,<b>Ford</b>(NYSE:<b><u>F</u></b>) announced that it is recalling 50,000 of its Mustang Mach-EEV over safety issues. Additionally, <b>Tesla</b>(NASDAQ:<b><u>TSLA</u></b>) has come under public fire over its safety record and the autopilot system found in its vehicles. At the same time, Chinese automakers have been hobbled by production shutdowns due to Covid-19 lockdowns.</p><p><b>What’s Next for NIO Stock</b></p><p>It will be important to see if Nio can resolve the trademark dispute with Audi quickly and with little financial penalty for the automaker. A protracted legal battle will not help NIO stock or the company’s European expansion. In the meantime, Nio’s share price continues to come under pressure and fall lower.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO Stock Falls 5% on Trademark Lawsuit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO Stock Falls 5% on Trademark Lawsuit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-16 22:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/06/nio-stock-falls-5-on-trademark-lawsuit/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nio(NIO) is down 4% today on news that European rival Volkswagen's(VWAGY) Audi has filed a trademark infringement lawsuit against it.At the same time, Jeffries has cut its forecast for electric ...</p>\n\n<a href=\"https://investorplace.com/2022/06/nio-stock-falls-5-on-trademark-lawsuit/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://investorplace.com/2022/06/nio-stock-falls-5-on-trademark-lawsuit/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186706257","content_text":"Nio(NIO) is down 4% today on news that European rival Volkswagen's(VWAGY) Audi has filed a trademark infringement lawsuit against it.At the same time, Jeffries has cut its forecast for electric vehicle (EV) sales this year and next, putting pressure on all EV stocks.The lawsuit from Audi threatens to hurt Nio's European expansion plans.Shares of Nio(NYSE:NIO) are down 4% today on news that the Chinese electric vehicle (EV) maker is facing legal action from rival Volkswagen’s(OTCMKTS:VWAGY) Audi over an alleged trademark violation. Reports of the lawsuit come at the same time Jeffries slashed its price target for EV sales, setting NIO stock up for a very bad trading day.Ironically, today’s downturn comes a day after Nio’sshare price rose more than 13% after a product launch in which it revealed its long-awaited ES7 electric SUV. So far in 2022, NIO stock has fallen more than 40% to trade at less than $20 per share.What Happened With NIO StockThe most consequential news is that Audi has filed a lawsuit in a Munich court against Nio, alleging the Shanghai-based company has infringed on its trademark. Specifically, the company claims Nio’s decision to name two of its models ES6 infringes on Audi’s trademark for its own S6 and S8 model vehicles.Nio, whose sales are predominantly in China, is now pushing into the European automotive market. It entered Norway last year with plans to begin sales in Germany, the Netherlands, Sweden and Denmark this year. Nio has said it expects to initiate its sales in Germany with its ET7 electric sedan.At the same time, Jeffries Financial Group lowered it forecast for worldwide EV sales this year to 8.7 million from 9 million previously. It also lowered its 2023 estimate to 11.5 million, down from an earlier estimate of 11.8 million. Jeffries cited the impact of inflation and higher interest rates as the reasons for its diminished outlook.Why It MattersThe Audi lawsuit is the latest blow to Nio’s share price this year. In recent months, the company has also had to contend with an investigation by the U.S. Securities and Exchange Commission (SEC) into its accounting practices. Nio has also faced slower-than-expected production due to Covid-19 lockdowns in China and was forced to list its shares on the Singapore Exchange over concerns that it might be delisted in New York.For the electric vehicle sector, Jeffries sales downgrade also comes at a bad time. In recent days,Ford(NYSE:F) announced that it is recalling 50,000 of its Mustang Mach-EEV over safety issues. Additionally, Tesla(NASDAQ:TSLA) has come under public fire over its safety record and the autopilot system found in its vehicles. At the same time, Chinese automakers have been hobbled by production shutdowns due to Covid-19 lockdowns.What’s Next for NIO StockIt will be important to see if Nio can resolve the trademark dispute with Audi quickly and with little financial penalty for the automaker. A protracted legal battle will not help NIO stock or the company’s European expansion. In the meantime, Nio’s share price continues to come under pressure and fall lower.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9923430029,"gmtCreate":1670892000361,"gmtModify":1676538454217,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099173660726180","idStr":"4099173660726180"},"themes":[],"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9923430029","repostId":"2290205419","repostType":4,"repost":{"id":"2290205419","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1670829569,"share":"https://ttm.financial/m/news/2290205419?lang=&edition=full_marsco","pubTime":"2022-12-12 15:19","market":"us","language":"en","title":"Microsoft to Buy About 4% Stake in LSEG As Part of Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2290205419","media":"Reuters","summary":"Dec 12  - London Stock Exchange Grouphas launched a 10-year partnership with Microsoftthat will see the U.S. tech giant buy an about 4% equity stake in the British company.Microsoft will buy LSEG shares from the Blackstone/Thomson ReutersConsortium, the bourse operator said on Monday.Thomson Reuters is the parent company of Reuters News.","content":"<html><head></head><body><p>Dec 12 (Reuters) - London Stock Exchange Group has launched a 10-year partnership with Microsoft that will see the U.S. tech giant buy an about 4% equity stake in the British company.</p><p>Microsoft will buy LSEG shares from the Blackstone/Thomson Reuters Consortium, the bourse operator said on Monday.</p><p>Thomson Reuters is the parent company of Reuters News.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft to Buy About 4% Stake in LSEG As Part of Partnership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft to Buy About 4% Stake in LSEG As Part of Partnership\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-12-12 15:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Dec 12 (Reuters) - London Stock Exchange Group has launched a 10-year partnership with Microsoft that will see the U.S. tech giant buy an about 4% equity stake in the British company.</p><p>Microsoft will buy LSEG shares from the Blackstone/Thomson Reuters Consortium, the bourse operator said on Monday.</p><p>Thomson Reuters is the parent company of Reuters News.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2290205419","content_text":"Dec 12 (Reuters) - London Stock Exchange Group has launched a 10-year partnership with Microsoft that will see the U.S. tech giant buy an about 4% equity stake in the British company.Microsoft will buy LSEG shares from the Blackstone/Thomson Reuters Consortium, the bourse operator said on Monday.Thomson Reuters is the parent company of Reuters News.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9934593075,"gmtCreate":1663280963398,"gmtModify":1676537240515,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099173660726180","idStr":"4099173660726180"},"themes":[],"htmlText":"Are vaccines still necessary?&nbsp;","listText":"Are vaccines still necessary?&nbsp;","text":"Are vaccines still necessary?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9934593075","repostId":"1112685413","repostType":4,"repost":{"id":"1112685413","kind":"news","pubTimestamp":1663252053,"share":"https://ttm.financial/m/news/1112685413?lang=&edition=full_marsco","pubTime":"2022-09-15 22:27","market":"us","language":"en","title":"Pfizer vs. Moderna: Which Vaccine-Maker Has More Upside?","url":"https://stock-news.laohu8.com/highlight/detail?id=1112685413","media":"TipRanks","summary":"Story HighlightsPfizer and Moderna are top COVID-19 stocks that could continue to be winners well af","content":"<div>\n<p>Story HighlightsPfizer and Moderna are top COVID-19 stocks that could continue to be winners well after the pandemic is over. Let’s check in with each stock and see where Wall Street stands on each ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/pfizer-vs-moderna-which-vaccine-maker-has-more-upside\">Web Link</a>\n\n</div>\n","source":"lsy1606183248679","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer vs. Moderna: Which Vaccine-Maker Has More Upside?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer vs. Moderna: Which Vaccine-Maker Has More Upside?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-15 22:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/article/pfizer-vs-moderna-which-vaccine-maker-has-more-upside><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Story HighlightsPfizer and Moderna are top COVID-19 stocks that could continue to be winners well after the pandemic is over. Let’s check in with each stock and see where Wall Street stands on each ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/pfizer-vs-moderna-which-vaccine-maker-has-more-upside\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.tipranks.com/news/article/pfizer-vs-moderna-which-vaccine-maker-has-more-upside","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112685413","content_text":"Story HighlightsPfizer and Moderna are top COVID-19 stocks that could continue to be winners well after the pandemic is over. Let’s check in with each stock and see where Wall Street stands on each name.Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) are the big-two COVID-19 vaccine makers that have seen shares fall back to Earth in recent months. Although both stocks may look tempting to investors, I believe Pfizer may have more upside potential.Undoubtedly, we’re still in a pandemic, but things are pretty much back to normal. America has reopened its doors, and things are unlikely to change, even if a new Omicron variant sparks an outbreak for the fall or winter season.Indeed, booster shots are a major reason the American economy can keep its doors open as the coronavirus continues spreading. We’ve learned to live with the disease, and with no end to the pandemic in sight, Pfizer and Moderna stand to continue extending their vaccine windfalls.In due time, the pandemic will end, and demand for vaccines could begin to fall alongside the severity of future strains. Nobody expected Pfizer or Moderna’s COVID-19 businesses to continue raking in impressive cash flows forever. Each stock sports a low single-digit price-to-earnings (P/E) multiple in anticipation of a drastic fall-off in vaccine demand.In any case, Pfizer and Moderna are two biopharma companies with innovation in their veins. The potential of mRNA technology could have the potential to be far-reaching, and it’s these two plays that seem like terrific buys on the dip, even as they move beyond COVID-19.With Moderna going after Pfizer and BioNTech for COVID-19 vaccine patent infringement, the two COVID-19 rivals could find themselves in a legal tussle for quite some time. In any case, don’t expect such a suit to impact supply ahead of future COVID-19 waves.Let’s look closely at Pfizer and Moderna to see how each firm stacks up going into a recession year and a post-COVID environment.PfizerPfizer is a biopharma behemoth that’s been on quite a spending spree of late, with the acquisition of Biohaven Pharmaceuticals for $11.6 billion and Blood Therapeutics for $5.4 billion. Such deals are intriguing and seem to be a terrific use of excess funds from the COVID-19 business.As Pfizer continues making considerable sums on booster shots, investors can expect Pfizer to continue to pursue opportunities in the space to keep its pipeline full and its growth rate elevated.Undoubtedly, Pfizer doesn’t have a track record for growth. It’s a $260 billion behemoth that’s been weighed down by a generics business for many years. With the generics business spun off and a new focus on growth, Pfizer seems more than capable of growing like a firm that’s a fraction of its size.The Biohaven and Blood Therapeutics deals add an impressive portfolio of drugs aboard, as well as promising candidates that could have blockbuster potential in the future. With Biohaven, Pfizer gains a promising migraine business and third-generation glutamate-modulation platform Troriluzole, among other very intriguing offerings. The migraine franchise should do wonders for helping Pfizer hold its own in the latter half of the decade once the COVID-19 business winds down.It isn’t just the migraine business that’s intriguing. Troriluzole is in phase three of clinical trials for treating OCD (obsessive-compulsive disorder) and Spinocerebellar Ataxia (SCA). The drug has blockbuster potential and could help Pfizer transition into a post-Comirnaty world.Pfizer is readying for the end of the COVID-19 windfall, but the COVID business may still have room to run into 2023 or even 2024. It’s hard to tell when the pandemic will end, but even if it doesn’t, Pfizer’s boosters and oral treatments will be vital in keeping things normal for the duration of the pandemic.Pfizer stock looks like a cheap biopharma stock to make it through a recession year. At writing, the stock trades at 8.9 times trailing earnings and just 2.7 times sales.Is Pfizer Stock a Buy, Sell, or Hold?Wall Street is bullish but muted on Pfizer stock with a Moderate Buy consensus rating. This is based on four Buys and seven Holds assigned in the past three months. With an average PFE stock price target of $56.20, analysts expect a 22% upside potential.ModernaModerna is betting big on mRNA technology, with a pipeline full of innovations with blockbuster potential. Unlike Pfizer, Moderna has more to lose if COVID-19 vaccine demand dissipates. In any case, demand may not be so quick to fade as the world gears for another wave of spread. In the latest quarter, Moderna saw COVID-19 vaccine revenues rise 8%. The company is on its way to hitting its $21 billion sales estimate.Beyond COVID-19, Moderna stock is more of a question mark. Various vaccine trials — including RSV (respiratory virus) — are in the late stages and could help spark the next leg higher for the stock, even if the economy falls into a recession over the next few months.Indeed, Moderna stock has the potential to fuel a lowly-correlated return moving forward. In any case, it’s all about boosters as the firm pushes for its next big thing. For a firm that delivered one of the biggest innovations with Spikevax over the past few years, I think Moderna can pull off another breakthrough.For now, investors are curbing their expectations. The stock boasts a 4.6 times trailing earnings multiple and a 2.7 times sales multiple. That’s not at all indicative of a pioneer in a nascent market full of potential. I don’t think Moderna stock is a trap or a one-hit wonder, even if vaccine demand were to sink rapidly through 2023. The pipeline is full of too much promise.What is the Price Target for MRNA Stock?Wall Street expects Moderna’s returns to be promising over the next year. Similar to Pfizer, analysts have a Moderate Buy consensus rating on Moderna based on four Buys, five Holds, and one Sell. However, with an average MRNA stock price target of $209.60, the upside potential equates to 50.8%.Takeaway: Pfizer Might be the Better BuyModerna and Pfizer are both great bets following their recent declines (23% and 71%, respectively). However, at this juncture, I prefer Pfizer stock because it looks better prepared for a move into a post-pandemic environment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":901,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9934591920,"gmtCreate":1663281011461,"gmtModify":1676537240548,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099173660726180","idStr":"4099173660726180"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9934591920","repostId":"1148570498","repostType":4,"repost":{"id":"1148570498","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1663249790,"share":"https://ttm.financial/m/news/1148570498?lang=&edition=full_marsco","pubTime":"2022-09-15 21:49","market":"us","language":"en","title":"EV Stocks Took off in Morning Trading, With Faraday Future Soaring Over 11% and Canoo Rising Nearly 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148570498","media":"Tiger Newspress","summary":"EV stocks took off in morning trading, with $Faraday Future Intelligent Electric Inc.(FFIE)$ soaring over 11% and $Canoo Inc.(GOEV)$ rising nearly 5%.","content":"<html><head></head><body><p>EV stocks took off in morning trading, with <a href=\"https://laohu8.com/S/FFIE\">Faraday Future Intelligent Electric Inc.</a> soaring over 11% and <a href=\"https://laohu8.com/S/GOEV\">Canoo Inc.</a> rising nearly 5%.<img src=\"https://static.tigerbbs.com/d55630e814b1927d668c6f95a774f051\" tg-width=\"259\" tg-height=\"391\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV Stocks Took off in Morning Trading, With Faraday Future Soaring Over 11% and Canoo Rising Nearly 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV Stocks Took off in Morning Trading, With Faraday Future Soaring Over 11% and Canoo Rising Nearly 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-09-15 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>EV stocks took off in morning trading, with <a href=\"https://laohu8.com/S/FFIE\">Faraday Future Intelligent Electric Inc.</a> soaring over 11% and <a href=\"https://laohu8.com/S/GOEV\">Canoo Inc.</a> rising nearly 5%.<img src=\"https://static.tigerbbs.com/d55630e814b1927d668c6f95a774f051\" tg-width=\"259\" tg-height=\"391\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148570498","content_text":"EV stocks took off in morning trading, with Faraday Future Intelligent Electric Inc. soaring over 11% and Canoo Inc. rising nearly 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1071,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9054438834,"gmtCreate":1655422403928,"gmtModify":1676535634044,"author":{"id":"4099173660726180","authorId":"4099173660726180","name":"jesslzh","avatar":"https://static.tigerbbs.com/4a45f712cd48040341f4e9bf06fe0881","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099173660726180","idStr":"4099173660726180"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9054438834","repostId":"2243842651","repostType":4,"repost":{"id":"2243842651","kind":"highlight","pubTimestamp":1655391848,"share":"https://ttm.financial/m/news/2243842651?lang=&edition=full_marsco","pubTime":"2022-06-16 23:04","market":"us","language":"en","title":"Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2243842651","media":"Motley Fool","summary":"These two blue-chip financial companies have been undervalued for a while.","content":"<html><head></head><body><p>The <b>S&amp;P 500</b> dipped into bear market territory earlier this week, down more than 20% from its early January peak. The broader market drop has brought down the valuations of some individual good stocks in numerous sectors and industries.</p><p>I&#39;ve had my eye on two stocks that have been on sale for quite a while now and were trading lower even before the market began to tank in November. For whatever reasons, investors have undervalued them despite their strong performances. Should investors take a chance on these two sale-priced stocks? Let&#39;s take a closer look.</p><h2>1. The case for Goldman Sachs</h2><p><b>Goldman Sachs</b> is currently trading at about $290 per share, down about 24% year to date, and based on its fundamentals and outlook, that&#39;s a bargain valuation.</p><p>The investment banking giant has a price-to-earnings (P/E) ratio of 5.6 and a forward P/E ratio of 7.7.</p><p>Further, consider its 5-year price/earnings-to-growth (PEG) ratio -- a metric that weighs the stock price relative to its expected earnings growth. At 0.2, that&#39;s another indicator of a cheap stock, as any PEG ratio under 1 is considered undervalued.</p><p>It&#39;s also trading at a price-to-book (P/B) ratio of 0.9 -- another sign that it&#39;s discounted, as a P/B of 1 indicates a stock trading at its actual value.</p><p>So why is Goldman Sachs a good buy at this low valuation? It is a market leader in two of its businesses, investment banking and global markets -- which is its institutional trading arm. While mergers and acquisitions activity has slowed considerably compared to last year, Goldman Sachs is still the leader in deals so far in 2022. And while equity trading has slowed, too, Goldman Sachs had a record quarter for fixed income trading. Also, it experienced strong growth in its consumer banking/wealth management businesses, which saw revenue increase 21% year over year. This offset losses in the asset management business, which suffered due to an overall decline in assets due to the falling stock market.</p><p>Even after its declines in this bear market, Goldman Sachs&#39; market leadership and diversity of revenue sources have it trading at a price nearly twice as much as it was at the bottom of its early pandemic plunge in March 2020. Yet it&#39;s still cheap by these metrics, which makes this a good time to pick up shares of this blue-chip financial institution.</p><h2>2. The case for Citigroup</h2><p>You certainly don&#39;t have to wait for a market crash to get <b>Citigroup</b> at a low valuation. The nation&#39;s third-largest bank by assets has been undervalued for several years now, due in part to the pandemic, but also due to its own issues related to risk management.</p><p>But Citigroup has been a relative outperformer compared to its megabank peers in 2022. It&#39;s only down about 20% year to date, and it remains extremely undervalued. It has a P/E ratio of 5.6 and a forward P/E of 7, with a PEG ratio of 0.4. Also, it has a P/B ratio of just 0.5. All of those metrics indicate a stock trading well below its value.</p><p>Renowned value stock investor Warren Buffett, chairman and CEO of <b>Berkshire Hathaway</b>, recognized that, as he added Citigroup to the conglomerate&#39;s portfolio in the first quarter.</p><p>What Buffett likely saw was that Citi was trading at a deep discount due in large part to its own past mistakes, but that the bank has made some key changes. Those started with bringing in a new CEO, Jane Fraser, who has refocused its strategy on its strengths and exited businesses that have underperformed. It has also invested close to $1 billion to improve its internal controls.</p><p>While Citigroup&#39;s transformation won&#39;t happen overnight, it&#39;s a good buy at this valuation. And the current rising interest rate environment should benefit it by boosting its interest income, as long as inflation can be brought into check and the U.S. economy doesn&#39;t fall into a recession.</p><p>When the economy and markets do eventually turn around, these two undervalued stocks will be in a good position to grow.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon't Wait for a Market Crash: These 2 Top Stocks Are on Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-16 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/06/16/dont-wait-for-market-crash-top-stocks-on-sale/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The S&P 500 dipped into bear market territory earlier this week, down more than 20% from its early January peak. The broader market drop has brought down the valuations of some individual good stocks ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/06/16/dont-wait-for-market-crash-top-stocks-on-sale/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛","C":"花旗"},"source_url":"https://www.fool.com/investing/2022/06/16/dont-wait-for-market-crash-top-stocks-on-sale/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2243842651","content_text":"The S&P 500 dipped into bear market territory earlier this week, down more than 20% from its early January peak. The broader market drop has brought down the valuations of some individual good stocks in numerous sectors and industries.I've had my eye on two stocks that have been on sale for quite a while now and were trading lower even before the market began to tank in November. For whatever reasons, investors have undervalued them despite their strong performances. Should investors take a chance on these two sale-priced stocks? Let's take a closer look.1. The case for Goldman SachsGoldman Sachs is currently trading at about $290 per share, down about 24% year to date, and based on its fundamentals and outlook, that's a bargain valuation.The investment banking giant has a price-to-earnings (P/E) ratio of 5.6 and a forward P/E ratio of 7.7.Further, consider its 5-year price/earnings-to-growth (PEG) ratio -- a metric that weighs the stock price relative to its expected earnings growth. At 0.2, that's another indicator of a cheap stock, as any PEG ratio under 1 is considered undervalued.It's also trading at a price-to-book (P/B) ratio of 0.9 -- another sign that it's discounted, as a P/B of 1 indicates a stock trading at its actual value.So why is Goldman Sachs a good buy at this low valuation? It is a market leader in two of its businesses, investment banking and global markets -- which is its institutional trading arm. While mergers and acquisitions activity has slowed considerably compared to last year, Goldman Sachs is still the leader in deals so far in 2022. And while equity trading has slowed, too, Goldman Sachs had a record quarter for fixed income trading. Also, it experienced strong growth in its consumer banking/wealth management businesses, which saw revenue increase 21% year over year. This offset losses in the asset management business, which suffered due to an overall decline in assets due to the falling stock market.Even after its declines in this bear market, Goldman Sachs' market leadership and diversity of revenue sources have it trading at a price nearly twice as much as it was at the bottom of its early pandemic plunge in March 2020. Yet it's still cheap by these metrics, which makes this a good time to pick up shares of this blue-chip financial institution.2. The case for CitigroupYou certainly don't have to wait for a market crash to get Citigroup at a low valuation. The nation's third-largest bank by assets has been undervalued for several years now, due in part to the pandemic, but also due to its own issues related to risk management.But Citigroup has been a relative outperformer compared to its megabank peers in 2022. It's only down about 20% year to date, and it remains extremely undervalued. It has a P/E ratio of 5.6 and a forward P/E of 7, with a PEG ratio of 0.4. Also, it has a P/B ratio of just 0.5. All of those metrics indicate a stock trading well below its value.Renowned value stock investor Warren Buffett, chairman and CEO of Berkshire Hathaway, recognized that, as he added Citigroup to the conglomerate's portfolio in the first quarter.What Buffett likely saw was that Citi was trading at a deep discount due in large part to its own past mistakes, but that the bank has made some key changes. Those started with bringing in a new CEO, Jane Fraser, who has refocused its strategy on its strengths and exited businesses that have underperformed. It has also invested close to $1 billion to improve its internal controls.While Citigroup's transformation won't happen overnight, it's a good buy at this valuation. And the current rising interest rate environment should benefit it by boosting its interest income, as long as inflation can be brought into check and the U.S. economy doesn't fall into a recession.When the economy and markets do eventually turn around, these two undervalued stocks will be in a good position to grow.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}